Concepedia

Author

Chengwen Liu

The University of Texas MD Anderson Cancer CenterORCID

Also Known As

C.‐W. Liu, Cheng-Wen LIU, Cheng-Wen Liu, Cheng-wen Liu, ChengWen Liu, Chengwen Liu, Cheng‐Wen Liu, Liu Chengwen, Liu, Chengwen

333

Publications

8.5K

Citations

41

H-Index

166

Concepts

All Affiliations

The University of Texas MD Anderson Cancer CenterThe University of Texas at AustinPeking UniversityBeijing National Laboratory for Molecular SciencesInstitute of Chemistry
CL

About

Chengwen Liu is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, engineering, and natural sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Engineering

15

22

814

2

Medicine

15

17

1.5K

3

Natural Sciences

14

16

783

4

Management

2

2

30

5

Public Health

1

1

22

Chengwen Liu

×

81

Publications

7.7K

Citations

39

H-Index

YearCitations

Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy

Weiyi Peng, Jie Qing Chen, Chengwen Liu,

Cancer Discovery

2015

1.5K

BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma

Dennie T. Frederick, Adriano Piris, Alexandria P. Cogdill,

Clinical Cancer Research

2013

934

Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion

Yared Hailemichael, Zhimin Dai, Nina Jaffarzad,

Nature Medicine

2013

444

PD-1 Blockade Enhances T-cell Migration to Tumors by Elevating IFN-γ Inducible Chemokines

Weiyi Peng, Chengwen Liu, Chunyu Xu,

Cancer Research

2012

425

BRAF Inhibition Increases Tumor Infiltration by T cells and Enhances the Antitumor Activity of Adoptive Immunotherapy in Mice

Chengwen Liu, Weiyi Peng, Chunyu Xu,

Clinical Cancer Research

2012

375

Plasmacytoid dendritic cells induce NK cell–dependent, tumor antigen–specific T cell cross-priming and tumor regression in mice

Chengwen Liu, Yanyan Lou, Gregory Lizée,

Journal of Clinical Investigation

2008

303

Oncogenic BRAF(V600E) Promotes Stromal Cell-Mediated Immunosuppression Via Induction of Interleukin-1 in Melanoma

Jahan S. Khalili, Shujuan Liu, Tania Rodríguez-Cruz,

Clinical Cancer Research

2012

296

Transduction of Tumor-Specific T Cells with CXCR2 Chemokine Receptor Improves Migration to Tumor and Antitumor Immune Responses

Weiyi Peng, Yang Ye, Brian Rabinovich,

Clinical Cancer Research

2010

217

HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes

Rina M. Mbofung, Jodi A. McKenzie, Shruti Malu,

Nature Communications

2017

148

AMOEBA+ Classical Potential for Modeling Molecular Interactions

Chengwen Liu, Jean‐Philip Piquemal, Pengyu Ren

Journal of Chemical Theory and Computation

2019

139

Page 1